Strides Pharma Receives US FDA Approval for Fluoxetine Tabs 60 mg
Monday, 16 September 2024, 04:10
Strides Pharma Science Achievements
Strides Pharma Science has made great strides in pharmaceutical innovation with the recent US FDA approval for fluoxetine tabs 60 mg. Fluoxetine, a well-known SSRI, is effective in treating Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, Panic Disorder, and Agoraphobia.
Implications of FDA Approval
This approval by Strides Pharma signifies a vital development for mental health therapies. Fluoxetine taps into the growing need for effective treatment solutions in today's healthcare landscape.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.